NCT00099437 · Interventional trial
Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
Overall registry status Active not recruiting
Phase 3
Conditions Breast Cancer
Delaware Valley sites
- Research Site · Voorhees Township, NJ · Camden County
First posted
Registry updated
Added to the directory